Montgomery RB - Search Results

1

Schweizer MT, Gulati R, Mostaghel EA, Nelson PS, Montgomery RB, Yu EY, Cheng HH. Schweizer MT, et al. Among authors: montgomery rb. Med Oncol. 2016 Jul;33(7):77. doi: 10.1007/s12032-016-0793-1. Epub 2016 Jun 14. Med Oncol. 2016. PMID: 27300548 Free PMC article.

2

Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells.

Montgomery RB, Bonham M, Nelson PS, Grim J, Makary E, Vessella R, Stahl WL. Montgomery RB, et al. Prostate. 2005 Oct 1;65(2):141-50. doi: 10.1002/pros.20246. Prostate. 2005. PMID: 15924336

3

Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.

Wu JD, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, Montgomery RB, Ludwig DL, Plymate SR. Wu JD, et al. Among authors: montgomery rb. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6153-60. doi: 10.1158/1078-0432.CCR-06-0443. Clin Cancer Res. 2006. PMID: 17062692

4

The basic biochemistry and molecular events of hormone therapy.

Mostaghel EA, Montgomery RB, Lin DW. Mostaghel EA, et al. Among authors: montgomery rb. Curr Urol Rep. 2007 May;8(3):224-32. doi: 10.1007/s11934-007-0010-z. Curr Urol Rep. 2007. PMID: 17459272 Review.

5

Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.

Montgomery RB, Nelson PS, Lin D, Ryan CW, Garzotto M, Beer TM. Montgomery RB, et al. Cancer. 2007 Sep 1;110(5):996-1002. doi: 10.1002/cncr.22917. Cancer. 2007. PMID: 17639587 Free article. Clinical Trial.

6

An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer.

Plymate SR, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, Montgomery RB, Ludwig DL, Wu JD. Plymate SR, et al. Among authors: montgomery rb. Clin Cancer Res. 2007 Nov 1;13(21):6429-39. doi: 10.1158/1078-0432.CCR-07-0648. Clin Cancer Res. 2007. PMID: 17975155

7

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS. Montgomery RB, et al. Cancer Res. 2008 Jun 1;68(11):4447-54. doi: 10.1158/0008-5472.CAN-08-0249. Cancer Res. 2008. PMID: 18519708 Free PMC article.

8

HE3235 inhibits growth of castration-resistant prostate cancer.

Koreckij TD, Trauger RJ, Montgomery RB, Pitts TE, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E. Koreckij TD, et al. Among authors: montgomery rb. Neoplasia. 2009 Nov;11(11):1216-25. doi: 10.1593/neo.09960. Neoplasia. 2009. PMID: 19881957 Free PMC article.

9

Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.

Wang D, Montgomery RB, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ. Wang D, et al. Among authors: montgomery rb. Cancer Res. 2009 Dec 15;69(24):9448-56. doi: 10.1158/0008-5472.CAN-09-1903. Cancer Res. 2009. PMID: 19934328 Free PMC article.

10

Intraprostatic steroidogenic enzymes - letter.

Mostaghel E, Nelson PS, Nelson C, Montgomery RB. Mostaghel E, et al. Among authors: montgomery rb. Cancer Res. 2010 Oct 15;70(20):8247-9; author reply 8249-50. doi: 10.1158/0008-5472.CAN-10-1458. Epub 2010 Oct 12. Cancer Res. 2010. PMID: 20940409 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters